shutterstock_2180131035_jhvephoto

JHVEPhoto / Shutterstock.com

13 July 2023Big PharmaMarisa Woutersen

Illumina fined record €432m for completing Grail merger before EC approval

Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

BGI wins $333m in DNA patent suit with Illumina

9 May 2022 Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.

More on this story

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

BGI wins $333m in DNA patent suit with Illumina

9 May 2022 Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.

More on this story

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

BGI wins $333m in DNA patent suit with Illumina

9 May 2022 Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB